Atlas Trials

Raynaud's Disease

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Raynaud's Disease

RecordFirmDate
Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon (NCT02683408)Primus Pharmaceuticals2016-02-01
Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR) (NCT02396238)Cytori Therapeutics2015-05-15
Nova Cold Hands Raynaud's Disorder, a Disease Which Results in Decreased Blood Flow to the Hands and Feet. (NCT02615964)University of Illinois at Chicago2015-05-01
A Two-Part Study of BOTOX® Therapy for Ischemic Digits (NCT01309802)Southern Illinois University2011-05-01
A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon (NCT00577304)MediQuest Therapeutics2007-12-01
Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease (NCT00528242)Response Pharmaceuticals2007-06-01
Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon (NCT00480753)MediQuest Therapeutics2007-05-01
St. John's Wort in the Treatment of Raynaud's Phenomenon (NCT00351117)London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2007-03-01
Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon (NCT00419419)MediQuest Therapeutics2006-12-01
Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon (NCT00378521)MediQuest Therapeutics2006-07-01
Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon (NCT00266669)MediQuest Therapeutics2005-12-01
Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon (NCT00048776)Otsuka America Pharmaceutical2001-10-01
Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon (NCT00048763)Otsuka America Pharmaceutical2001-10-01
Raynaud's Treatment Study (RTS) (NCT00000530)National Heart, Lung, and Blood Institute (NHLBI)1992-09-01

Track Raynaud's Disease automatically

Every clearance here is in the API, with alerts when new ones post.